|Home page  | Editorial   | Journal  |  Guidelines to authors |  Contact  |
 

Acta Medica Medianae
Vol. 45
No 4, October, 2006
UDK 61
YU ISSN 0365-4478
 

Contact:
Mihajlo B Jakovljevic
Department of clinical and  experimental Farmacology of Faculty of Medicine
69 Svetozar Markovic Street
34 000 Kragujevac, Serbia
Phone: 064 295 25 18
E-mail
: mihajlo23@yahoo.com

 

Copyright 2006 by Faculty  of Medicine, University of Nis

BIOEQUIVALENCE STUDIES

 Mihajlo B Jakovljević and Slobodan M Janković

Department of clinical and  experimental Farmacology of Faculty of Medicine in Kragujevac

  Development of pharmaceutical technology and occurence of different dosage forms and routes of administration of the same, well-known drugs leaded to greater role of bioequivalence testing. In this review, we would like to emphasize some aspects of bioequivalence testing between brand name and generic drug forms in both in vitro and in vivo conditions. We also consider important to present some examples of negative bioequivalence from marketed products in the past, together with the serious cosequences of their use. Acta Medica Medianae 2006; 45(4):50-55.

Key words: bioequivalence, brand-name drug, generic drug, formulation, phar-maceutical technology